Skip to main content
Top

PharmacoEconomics

Issue 6/2011

Content (8 Articles)

Commentary

The Appropriate Elicitation of Expert Opinion in Economic Models

William Sullivan, Katherine Payne

Review Article

Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US

Bin Zhang, Prina Z. Donga, Mitra Corral, Medha Sasane, Jeffrey D. Miller, Chris L. Pashos

Review Article

Health Technology Funding Decision-Making Processes Around the World

Tania Stafinski, Devidas Menon, Donald J. Philippon, Christopher McCabe

Original Research Article

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

James G. Xenakis, Elizabeth T. Kinter, K. Jack Ishak, Alexandra J. Ward, Jenő P. Marton, Richard J. Willke, Simon Davies, J. Jaime Caro

Original Research Article

The Direct Medical Costs Associated with Suspected Heparin-Induced Thrombocytopenia

Natasha Nanwa, Nicole Mittmann, Sandra Knowles, Claudia Bucci, Rita Selby, Neil Shear, Scott E. Walker, William Geerts

Original Research Article

A Value Set for the EQ-5D Based on Experienced Health States

Reiner Leidl, Peter Reitmeir

Adis Pharmacoeconomic Drug Profile

Intravenous Esomeprazole

Gillian M. Keating

Correspondence

PAID 1.0 in Practice